Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01129167 · ClinicalTrials.gov registry record
Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 1,052
- Enrollment target
NCT01129167: Completed study, sponsored by Columbia University.
NCT01129167 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 1,052 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01129167 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 1,052 participants
- Enrollment target
Study Summary
Pancreatic cancer often spreads through local invasion into local structures, including fat, blood vessels, nerves, and nearby organs (stomach, duodenum, spleen, bile duct). Local microscopic invasion is associated with recurrence of pancreatic cancer after pancreatic resection, such that even if the original cancer is surgically removed, microscopic areas of cancer often remain. Data on the patterns of local invasion by pancreatic cancer have not been published. In this study, The investigators hope to investigate the frequency of the various methods of local invasion of pancreatic adenocarcinoma. This would help the investigators better understand how pancreatic cancer spreads, and determine what cancers are not resectable.
Primary Outcome
The clinical and pathology information from the CUMC surgical database will be reviewed to determine the frequency of the various modalities of local invasion of pancreatic adenocarcinoma. This includes: peripancreatic fat invasion, neural/perineural invasion, vascular invasion, macrovascular invasion, duodenal invasion, bile duct invasion, splenic invasion,and gastric invasion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,052 participants |
| Start Date | 2009-09-15 |
| Est. Completion | 2022-09-30 |
What the finished NCT01129167 record still lists
NCT01129167 is an observational study that tracks outcomes without assigning an intervention. Its 1,052 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01129167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01129167 about?
NCT01129167 is a clinical study titled "Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma". Pancreatic cancer often spreads through local invasion into local structures, including fat, blood vessels, nerves, and nearby organs (stomach, duodenum, spleen, bile duct). Local microscopic invasion is associated with recurrence of pancreatic cancer after pancreatic resection, such that even if th...
What is the current status of trial NCT01129167?
This trial is currently completed. The enrollment target is 1,052 participants. The study started on 2009-09-15. Estimated completion is 2022-09-30.
Who is sponsoring clinical trial NCT01129167?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI